Atara Biotherapeutics (ATRA) Net Cash Flow (QoQ) (2014 - 2026)
Atara Biotherapeutics (ATRA) Net Cash Flow (QoQ) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Atara Biotherapeutics |
134.61 Mn |
126.21 Mn |
392,000.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-104.45% |
| Dec 31, 2025 |
124.55% |
| Sep 30, 2025 |
-482.75% |
| Jun 30, 2025 |
126.06% |
| Mar 31, 2025 |
47.77% |
| Dec 31, 2024 |
-241.51% |
| Sep 30, 2024 |
501.25% |
| Jun 30, 2024 |
-140.81% |
| Mar 31, 2024 |
123.74% |
| Dec 31, 2023 |
-306.16% |
| Sep 30, 2023 |
764.54% |
| Jun 30, 2023 |
93.57% |
| Mar 31, 2023 |
-265.99% |
| Dec 31, 2022 |
577.72% |
| Sep 30, 2022 |
82.01% |
| Jun 30, 2022 |
-594.17% |
| Mar 31, 2022 |
37.36% |
| Dec 31, 2021 |
33.08% |
| Sep 30, 2021 |
60.92% |
| Jun 30, 2021 |
44.75% |
